Mad Money w/ Jim Cramer

Cramer discusses NVIDIA scandal, CoreWeave demand, Anthropic profitability, and restaurant rotation

48 min Listen to the original Episode page
Artificial IntelligenceData CentersSemiconductorsRestaurant StocksBiopharmaLightning Round

Summary

Jim Cramer addresses market reactions to a sex scandal involving NVIDIA CEO Jensen Huang, noting that data center stocks rallied despite the news. He highlights an interview with CoreWeave CEO Michael Intrator, who claims compute demand is ten times oversubscribed for 2027 and that older NVIDIA chips are being recontracted at a premium. Cramer also analyzes Anthropic's financials, pointing out adjusted profitability driven by non-cash charges and massive future infrastructure spending plans. The episode shifts to a rotation into restaurant stocks like Wingstop and Shake Shack, followed by an interview with Teva Pharmaceutical CEO Richard Francis regarding the company's shift to biopharma. The segment concludes with a Lightning Round featuring recommendations for Alibaba and Energy Transfer, and rejections for DraftKings and Netskope.

Episode sections

  1. 0:00 – 1:17

    Intro and Sponsor Reads

    The episode begins with sponsor advertisements for Amazon, Edward Jones, and CNBC Changemakers, followed by Jim Cramer's standard show intro and mission statement.

  2. 1:17 – 3:24

    NVIDIA Scandal and Data Center Sector Outlook

    Cramer discusses the negative impact of a sex scandal involving NVIDIA CEO Jensen Huang on investor sentiment, noting that despite this, data center stocks rallied. He mentions his investment trust has taken some positions off the table but remains overweight in the sector due to strong AI demand.

  3. 3:24 – 14:43

    CoreWeave Interview Highlights

    Cramer summarizes an interview with Michael Intrator, CEO of CoreWeave, who argues that demand for compute exceeds supply, citing ten times oversubscription for 2027. Intrator explains that CoreWeave has adapted its debt structure using customer prepayments and that NVIDIA chip contracts are being renewed at a 20-50% premium.

  4. 14:43 – 19:02

    Anthropic IPO Profitability Analysis

    Cramer analyzes Anthropic's financials ahead of its IPO, noting it achieved adjusted operating profitability in Q2 2026. He highlights a massive $94 billion non-cash charge related to convertible notes and SAFE agreements with partners like Google and Amazon, which turned a GAAP net loss of $104 billion into an adjusted net income of $5.6 billion.

  5. 19:02 – 23:53

    Anthropic Future Spending and Growth Requirements

    Cramer points out that Anthropic has raised $141 billion but holds $132 billion in cash, largely because it pays for compute with equity stakes rather than cash. He emphasizes Anthropic's commitment to spend approximately $900 billion on infrastructure by 2030, requiring hundreds of billions in annual revenue to maintain profitability.

  6. 23:53 – 25:42

    Restaurant Stocks Rotation

    Cramer discusses a market rotation from tech to consumer discretionary, specifically restaurant stocks. He notes positive retail and food services sales in August and September and introduces analyst Bob Lang, who identifies upside in Wingstop, Shake Shack, and Restaurant Brands International.

  7. 25:42 – 28:03

    Technical Analysis of Wingstop and Shake Shack

    Lang analyzes Wingstop (WING), noting a 74% rally from September lows and a bullish MACD signal. He also analyzes Shake Shack (SHAK), highlighting a breakout above the 200-day moving average and bullish options flow, suggesting potential upside if the May gap is filled.

  8. 28:03 – 29:56

    Restaurant Brands International (QSR) Outlook

    Lang discusses QSR Hotels, parent of Burger King and Popeyes, noting a strong start to the month and a bullish MACD flip. He suggests that a breakout above the $81-$82 resistance level could drive the stock to triple digits.

  9. 29:56 – 30:34

    Darden Restaurants and Teva Pharmaceutical Intro

    Jim Cramer advises buying Darden Restaurants (DRI) despite recent price spikes, citing great value at Olive Garden. He then introduces an exclusive interview with Teva Pharmaceutical CEO Richard Francis following Teva's strong earnings and a raised sales forecast.

  10. 30:34 – 34:47

    Teva Pharmaceutical CEO Interview: Strategy and Pipeline

    Cramer interviews Richard Francis, who explains Teva's transformation from a generics company to a biopharma focused on high-probability CNS treatments. Francis highlights the success of Wellbutrin (alpalisopridone) for schizophrenia and the acquisition of BioXL's assets for agitation in schizophrenia and bipolar disorder.

  11. 34:47 – 37:23

    Teva Pipeline: Migraine, Bipolar, and Future Launches

    Francis details the commercial success of Ajovy for migraine, noting its pediatric indication and strong market share growth. He outlines upcoming launches including Ekopipan for Tourette syndrome and treatments for tardive dyskinesia, aiming for a launch every 18 months after 2030.

  12. 37:23 – 39:25

    Lightning Round: Alibaba, Cyclore Metals, DraftKings

    Cramer names Alibaba (BABA) as the only Chinese stock he would buy due to weak consumer sentiment elsewhere. He recommends Cyclore Metals (TGB) as a speculative copper play for data centers and advises against DraftKings (DKNG) due to excessive competition and high customer acquisition costs.

  13. 39:25 – 41:04

    Lightning Round: Origin Bank, Pound Sterling, Energy Transfer

    Cramer recommends buying Origin Bank (OBK) for its consolidation potential. He values Pound Sterling (PSTG) at $200, noting strong execution by CEO Alex Karp. He advises buying more Energy Transfer (ET) for himself but suggests growth stocks like JNJ or P&G for his grandson.

  14. 41:04 – 47:47

    Lightning Round: Netskope and Veterans Day Tribute

    Cramer rejects Netskope (NTSK), stating CrowdStrike and Palo Alto Networks are sufficient for cloud security. He then delivers a Veterans Day tribute, honoring the late FedEx founder Fred Smith for his military service in Vietnam and his impact on veterans' causes.

Assets discussed

AssetKindStanceContext
NVIDIANVDAequitymixedEven if you are a huge believer in something. the events at NVIDIA, including the likelihood tonight that CEO Jensen Wong would be out at the company, perhaps as early as tonight, because of another sex scandal, this time with a high-ranking employee, as well as the negative impact to the data
JOHNSON & JOHNSONJNJequitybullishrather be in Colgate or Johnson
Meta PlatformsMETAequitymixedWell I bought Meta just ahead of earnings, which turned out to be a mistake. And I've made a lot of money off that stock over the years, but I I was trying to get back in it and uh
AlphabetGOOGLequityneutralOver the past couple years, Anthropic has reached wide-ranging agreements with some partners. Yeah, part big Big name partners, uh, Google, Amazon. and that include uh many different things. For example, Anthropic gets compute resources from these companies and distribution for its models via their cloud platforms.
AmazonAMZNequityneutralOver the past couple years, Anthropic has reached wide-ranging agreements with some partners. Yeah, part big Big name partners, uh, Google, Amazon. and that include uh many different things. For example, Anthropic gets compute resources from these companies and distribution for its models via their cloud platforms.
MicrosoftMSFTequityneutralIt has others with Google and Amazon, as well as Microsoft, and a couple of neo clouds, Nscale, Lambda.

“Stance” is how the speakers talked about the asset, not a recommendation.

Claims worth verifying

NVIDIA CEO Jensen Huang is likely to be out of the company due to a sex scandal with a high-ranking employee.

Unidentified speaker (UNKNOWN) ·1:17

How to verify: Check NVIDIA press releases or SEC filings (Form 8-K) for executive departures around November 2026; review news archives for reports on the scandal. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Primary source

The Dow climbed 255 points, the S&P 500 jumped 1.31%, and the NASDAQ soared 1.6% on the day of the broadcast.

Unidentified speaker (speaker_1) ·2:15

How to verify: Check historical market data from Yahoo Finance, Bloomberg, or CNBC for the trading day of November 11, 2026. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

CoreWeave is ten times oversubscribed for compute demand in 2027.

Unidentified speaker (speaker_0) ·5:05

How to verify: Review CoreWeave's investor presentations or earnings calls for capacity utilization and backlog data for 2026. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

CoreWeave's bonds offer a 15% yield.

Unidentified speaker (UNKNOWN) ·5:35

How to verify: Check bond trading platforms like Bloomberg or FRED for the yield on CoreWeave's outstanding debt securities. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Anthropic achieved profitability on an adjusted operating income basis in Q2 2026.

Unidentified speaker (speaker_0) ·15:09

How to verify: Review Anthropic's S-1 filing or press releases for Q2 2026 financial results. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Primary source

Anthropic reported a net loss of just over $104 billion through the first nine months of 2026.

Unidentified speaker (UNKNOWN) ·17:12

How to verify: Review Anthropic's S-1 filing for audited financial statements covering the nine months ended September 30, 2026. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Primary source

Anthropic's adjusted net income showed a profit of $5.6 billion for the first nine months of 2026.

Unidentified speaker (speaker_0) ·17:32

How to verify: Review Anthropic's S-1 filing for reconciliations of GAAP to non-GAAP financial measures. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Primary source

Anthropic has raised approximately $141 billion of capital since inception.

Unidentified speaker (speaker_0) ·19:02

How to verify: Review Anthropic's S-1 filing for the 'Use of Proceeds' or 'Capitalization' sections detailing total funding raised. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Primary source

Anthropic has $132 billion in cash, cash equivalents, and short-term investments as of the end of September 2026.

Unidentified speaker (speaker_0) ·19:14

How to verify: Review Anthropic's S-1 filing for the Balance Sheet as of September 30, 2026. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Primary source

Anthropic is committed to spend approximately $900 billion on compute and infrastructure, with about $70 billion expected in the next year.

Unidentified speaker (speaker_0) ·20:53

How to verify: Review Anthropic's S-1 filing for 'Risk Factors' or 'Management's Discussion and Analysis' detailing future capital commitments. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Primary source

Darden offers great value at Olive Garden and the stock will go higher despite being on a spike.

Unidentified speaker (UNKNOWN) ·30:02

How to verify: Check Darden Restaurants (DRI) stock price history and Olive Garden sales data via SEC 10-K filings and company press releases. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Primary source

Teva's stock was a $9 stock when Richard Francis took the job in early 2023 and is now above $43.

Unidentified speaker (speaker_0) ·30:54

How to verify: Verify Teva Pharmaceutical (TEVA) stock price on 2026-01-01 and current price via financial data providers like Bloomberg or Yahoo Finance. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Teva aims to bring in six to seven billion dollars a year in innovative medicines by 2030.

Unidentified speaker (speaker_0) ·30:54

How to verify: Review Teva's Investor Day presentation materials or Q3 2026 earnings release for forward-looking guidance. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Teva launched Wellbutrin (alpalisopridone) a few weeks prior to the interview.

Unidentified speaker (speaker_1) ·32:33

How to verify: Check FDA approval dates or Teva press releases for the launch of alpalisopridone (brand name likely Wellbutrin or similar, verify exact brand name in FDA database). For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Ajovy is a long-acting injectable CGRP treatment for migraine with peak sales of over a billion dollars.

Unidentified speaker (speaker_0) ·35:09

How to verify: Review Teva's financial reports for Ajovy sales figures and FDA labels for its mechanism of action. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Teva acquired assets from BioXL to treat agitation for schizophrenia and bipolar.

Unidentified speaker (speaker_1) ·34:22

How to verify: Search SEC filings (Schedule 14 or 8-K) for Teva's acquisition of BioXL assets. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Primary source

Ekopipan is a treatment for Tourette syndrome launching in 2027.

Unidentified speaker (UNKNOWN) ·36:04

How to verify: Check Teva's pipeline updates or FDA orphan drug designations for Ekopipan. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Alibaba is the only Chinese stock Jim Cramer would possibly buy.

Unidentified speaker (UNKNOWN) ·37:46

How to verify: This is a subjective opinion; verify via transcript or video archive of the show. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

DraftKings is suffering from withering competition and high customer acquisition costs.

Unidentified speaker (speaker_0) ·38:49

How to verify: Review DraftKings (DKNG) Q3 2026 earnings call transcript for customer acquisition cost metrics and competitive landscape analysis. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Fred Smith, FedEx founder, retired as a captain in the Marine Corps after two tours in Vietnam and received the Silver Star.

Unidentified speaker (UNKNOWN) ·44:27

How to verify: Verify Fred Smith's military service record via FedEx corporate history pages or public military records. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Do your own research

  • Verify NVIDIA's official statement and SEC filings regarding CEO Jensen Huang's employment status and any related disclosures.
  • Check CoreWeave's latest 10-K or 10-Q filings for debt structure details, customer prepayment terms, and NVIDIA contract renewals.
  • Review Anthropic's S-1 filing for IPO details, including the $94 billion non-cash charge breakdown and GAAP vs. Adjusted earnings reconciliation.
  • Analyze Wingstop (WING), Shake Shack (SHAK), and Restaurant Brands International (QSR) recent earnings reports and technical indicators (MACD, moving averages) cited by analyst Bob Lang.
  • Examine Teva Pharmaceutical's (TEVA) latest earnings release and press releases for Wellbutrin, Ajovy, and pipeline drug progress.
  • Assess DraftKings (DKNG) customer acquisition costs and competitive landscape data to evaluate Cramer's rejection of the stock.
  • Check Alibaba's (BABA) financial statements and shareholder structure to verify claims about American financial backing and Chinese consumer sentiment.
  • Review Energy Transfer (ET) dividend history and coverage ratio to assess its suitability as a dividend growth holding for long-term investors.
Full transcriptexpand
0:00
Unidentified speaker (UNKNOWN): In
0:01
Unidentified speaker (speaker_0): communities across Canada, hourly Amazon employees earn an average of over $26 an hour. Employees also have the opportunity to grow their skills and their paycheck by enrolling in free skills training programs for in-demand fields like software development and information technology.
0:22
Unidentified speaker (speaker_0): Learn more at about aboutAmazon.ca. Amazon.ca
0:30
Unidentified speaker (speaker_1): How does Edward Jones do money differently?
0:33
Unidentified speaker (speaker_2): Our financial advisor would listen to us and actually really get to the meat and potatoes of what our lifestyle is and what we believe in.
0:42
Unidentified speaker (speaker_3): Knowing our financial advisor was always there. We could can call him with anything at any time.
0:49
Unidentified speaker (speaker_1): We do money differently. by providing advice that actually fits you.
1:01
Unidentified speaker (UNKNOWN): My
1:01
Unidentified speaker (speaker_1): mission is simple. To make you money. I'm here to level the playing field for all investors. There's always a bull market somewhere, and I promise to help you find it. Mad Money starts now.
1:17
Unidentified speaker (UNKNOWN): Hey,
1:17
Unidentified speaker (speaker_1): I'm Kramer. Welcome to Mad Money. Welcome to Kramerica. Other people, my friends, I'm just trying to save you some money. My job is not just to entertain, but to tell us it is. So call me at 1-800-743 CBC or tweet me at Jim Kramer.
1:33
Unidentified speaker (speaker_1): Sometimes you need a reality check. Even if you are a huge believer in something. the events at NVIDIA, including the likelihood tonight that CEO Jensen Wong would be out at the company, perhaps as early as tonight, because of another sex scandal, this time with a high-ranking employee, as well as the negative impact to the data
1:53
Unidentified speaker (speaker_1): center story stemming from the outcome of the big blue wave, have shaken me, made me gun shy about a host of tech stocks, many of which have cost investors fortunes.
2:02
Unidentified speaker (UNKNOWN): But on
2:03
Unidentified speaker (speaker_1): a day when the Sempic Doctor stocks shone on a day, while the rest of the averages yawned, Dow climbing 255 points, SP jumping 1.31%, NASDAQ soaring 1.6%,
2:15
Unidentified speaker (speaker_1): we got some concrete evidence that you write off this group at your own peril. We want to stay diversified, but giving up on the data center stocks entirely may cause you to miss a good amount of upside. From my travel trust, which you can join by uh going to the CNBC Investing Club, we've taken some data center and related
2:34
Unidentified speaker (speaker_1): stocks off the table. Unfortunately, not NVIDIA.
2:40
Unidentified speaker (speaker_1): Because our composure and our prudence dictates that to have so much data center is still too dicey. I'm not changing that position, even after some of these stocks are now above where we sold them. Still, we've left plenty of exposure to the group, which includes semis, software, networking, builders, turbines, and cooling equipment, because we think the AI theme has much
3:00
Unidentified speaker (speaker_1): more room to run. But to keep what we call an overweight position in the group these days, you need nerves of tungsten and the confidence of a high-wire walker. That's why I thought an interview we did this very morning on Squawk of the Street with Michael Intrader, the CEO of the leading NeoCloud Core Weave, was so refreshing and reassuring, particularly versus
3:20
Unidentified speaker (speaker_1): the hideous news that seems to be coming out of NVIDIA.
3:24
Unidentified speaker (UNKNOWN): With
3:24
Unidentified speaker (speaker_1): the big blue wave, a couple of high-profile hedge fund blow ups, the weakness in the merger market with Marvell Tech and Momentum, and the heartbreak of an NVIDIA possibly without Jensen Wong, all things considered,
3:36
Unidentified speaker (UNKNOWN): I would
3:36
Unidentified speaker (speaker_1): rather be in Colgate or Johnson
3:38
Unidentified speaker (UNKNOWN): ⁇
3:38
Unidentified speaker (speaker_1): Johnson. The greatest investing story ever told became almost overnight a blight on our country, with its chief spokesperson caught up in some tawdry spy scandal that made Thornos look like child's play. With another revelation tonight, Jensen
3:53
Unidentified speaker (speaker_1): Gonner.
3:56
Unidentified speaker (speaker_1): Unlike print, television interviews tend to live for a few minutes and then die. Most of the time they are immediately cremated. But I don't want this one to end up in an urn on top of your TV set. So let me tell you what NTrader said, which might turn you into less of a skeptic as we head into what most likely will be the biggest IPO of all time, anthropic. While the
4:16
Unidentified speaker (speaker_1): bankers pitched a $1.3 to $1.4 trillion valuation yesterday morning, by last night there were already rumors it could be increased to $1.5 trillion. Meaning by this time next week, we'll be talking maybe $1.6, $1.7 trillion. Seems that seems totally reasonable.
4:32
Unidentified speaker (UNKNOWN): We were a little prosecutorial during the interview this morning with Intrader because his company, Quarry, was heavily in debt, in large part because InTrader is such a huge believer in the long-term value of the data center itself. He's a gigantic buyer of NVIDIA chips, which cost fortunes. So he has to borrow fortunes to do so. Fortunes that look to be far in excess of his
4:51
Unidentified speaker (UNKNOWN): company's means, at least right now. But the first thing Intrader did was disabuse us for the value of what he's buying, explaining that
4:59
Unidentified speaker (speaker_0): demand for compute, that's the end product of what he buys for it, exceeds the supply of
5:04
Unidentified speaker (UNKNOWN): it. They
5:05
Unidentified speaker (speaker_0): are, he said, ten times oversubscribed for twenty twenty-seven. And he added demand for twenty 2028 twenty-eight is also multiples of what he can provide. What a bullish story.
5:15
Unidentified speaker (UNKNOWN): That
5:15
Unidentified speaker (speaker_0): insatiable demand has allowed him to raise price for his services pretty consistently, which expands his gross margins. A terrific barometer of future profits, even if they aren't there today.
5:25
Unidentified speaker (UNKNOWN): He was
5:26
Unidentified speaker (speaker_1): borrowing money in the open market by issuing bonds, but those bonds have been clobbered to the point where they now offer a 15% yield. Now that's usually a sign of pending failure.
5:35
Unidentified speaker (UNKNOWN): So
5:35
Unidentified speaker (speaker_1): he's adapted, instead, taking down a different kind of debt that has customer pre prepayments to find his GPU buying to NVIDIA. His debt problem is no longer front end center. When I pressed him, I asked him why he doesn't just go into the open market and buy those bonds that are trading so poorly. He admitted that he said he's tempted because he thinks
5:53
Unidentified speaker (UNKNOWN): they're very cheap. But ultimately he still believes that he can make an even better return building and running data centers. In any case, I think you can take the red flag off the table about that issue.
6:03
Unidentified speaker (UNKNOWN): But how about the big blue wave and the political blowback that now seems to doom the data center in our country? He said it's not going to slow down the building one bit. And that if we don't build them here, then we'll simply go overseas where the rules aren't as strict. There is a massive groundswell of demand around the world of computing, he told us.
6:20
Unidentified speaker (speaker_0): Do you know he wrote an open letter recently to the new governor of Texas, Governor Elect, who seems lukewarm of
6:26
Unidentified speaker (UNKNOWN): the people?
6:27
Unidentified speaker (speaker_0): on data centers, explaining the court weave is what I call a white hat.
6:30
Unidentified speaker (UNKNOWN): He
6:30
Unidentified speaker (speaker_0): says he expects no trouble putting up data centers there. I felt very good after that because there hasn't been much in the way of positive sentiment ever since voters rejected data centers in forty of 41 ballot initiatives. Perhaps the most exciting part of the interview, although it was done before a lot more revelations,
6:48
Unidentified speaker (UNKNOWN): was when Intrader NTrader revealed that in NVIDIA video chips. chips he installed four years ago will soon be earning much more than when he bought them. The technology he said is coming off contract next year. It has now been recontracted at a 20 to 50 percent premium to their initial prices. That's right, starting next year, he'll begin earning more NVIDIA
7:08
Unidentified speaker (UNKNOWN): chips that he bought four years ago than he has been for any of the past four years. They have increased in
7:13
Unidentified speaker (speaker_1): value.
7:14
Unidentified speaker (UNKNOWN): Now keep in mind
7:15
Unidentified speaker (speaker_1): when he initially bought these chips, he borrowed on terms that matched his five-year customer contracts. By beginning next year, Corweave will own them free and clear. So all the revenue that it gets for renting them out is pure profit. Now that's incredible. When this company started, there were plenty of people who thought these NVIDIA chips would be worthless after one five-year contract. And
7:35
Unidentified speaker (speaker_1): Trader was making a huge bet on this technology, and it's looking like a good one.
7:39
Unidentified speaker (speaker_1): despite
7:40
Unidentified speaker (UNKNOWN): what
7:40
Unidentified speaker (speaker_1): Jensen Wong is said to be up to,
7:43
Unidentified speaker (UNKNOWN): which
7:44
Unidentified speaker (speaker_1): led somewhat obviously to Jensen, uh who is now the most pillory person in business. I wanted to know if Jensen were out, what would he think of the company? A pretty prescient question, his response.
7:59
Unidentified speaker (speaker_1): Look, NVIDIA is an extraordinary company. right? It is not one person, it is an extraordinary company. There are thousands of people over there that
8:09
Unidentified speaker (UNKNOWN): uh
8:09
Unidentified speaker (speaker_0): interface with thousands of people at my company every day. They they integrate on the technology, they integrate on the uh physical infrastructure, they integrate on the networking. We we have a close relationship with them up and down the companies, and they are
8:25
Unidentified speaker (UNKNOWN): uh uh a good company. a
8:27
Unidentified speaker (speaker_0): great partner. They have been a great partner for us for years, that they will continue to be a great partner for
8:32
Unidentified speaker (UNKNOWN): us. Look,
8:33
Unidentified speaker (speaker_1): I think the chips are obviously gonna be worthwhile, but as an NVIDIA shareholder, and that's my trust that owns it, it's definitely not gonna be enough.
8:41
Unidentified speaker (UNKNOWN): Look,
8:41
Unidentified speaker (speaker_1): a chestinless NVIDIA is an NVIDIA many will not want to own. I've always said own it, don't trade it. Well, I didn't think this would happen. I don't know anyone who did.
8:52
Unidentified speaker (speaker_1): It's very sobering.
8:53
Unidentified speaker (UNKNOWN): Well,
8:54
Unidentified speaker (speaker_1): Core Weaves quarter in this interview with Intrader or why the NASAC went higher today. Yes, it was shockingly positive. Core Weav's stock itself gained be at 25% today. Had he been less sanguine and less boisterous, maybe we would not have paid as much attention as we did. But that and the fact that Oracle, a builder of data centers, saw its it stock war after David Faber's
9:14
Unidentified speaker (speaker_1): interview with the C. CFO, Hillary Maxon, who talked about that company's success in building data centers, emboldened me. Clearly others felt the same way based on the action today. Would I still buy some more of these tech stocks right here if Jensen's out? The only things uh that would are inhead of us that could stop us would be a bad quarter of for
9:33
Unidentified speaker (speaker_1): NVIDIA. I don't think we'll get that, but obviously Jensen not on the quarter quarters, is going to shock people. What can you do? And then the Anthropic deal, which should trade next Thursday. Like I said in last night's installment of Know Your IPO series, Anthropic Squirrel sounds super, but stay tuned for the next leg tonight when we discuss profitability. Here's the
9:53
Unidentified speaker (speaker_1): bottom line: today the markets seem to feel much better about tech and the AI data
9:58
Unidentified speaker (speaker_0): center. If your portfolio benefited from that, you can thank Michael Intra. Intrader.
10:05
Unidentified speaker (UNKNOWN): Uh,
10:05
Unidentified speaker (speaker_0): as new supports certainly say, well, then tomorrow's gonna be a different story. And I am, yes, heart sick about it. I
10:12
Unidentified speaker (UNKNOWN): I
10:13
Unidentified speaker (speaker_0): thought I knew Jensen.
10:14
Unidentified speaker (UNKNOWN): Maybe
10:15
Unidentified speaker (speaker_0): we'll leave it at
10:15
Unidentified speaker (UNKNOWN): that.
10:17
Unidentified speaker (speaker_0): Speak to Gary in Alabama. Gary.
10:19
Unidentified speaker (UNKNOWN): Hey
10:19
Unidentified speaker (speaker_0): Jim. First of all, I wanna let you know I was one of your original investment club members, and I really appreciate what you and Jeff do for guys like me who don't have time to to do the homework and you do that for me and I've made a lot of money with you. Thank you, Gary. That's really what you were trying to offer institutional research for individuals, but in a way that's far
10:39
Unidentified speaker (speaker_0): more interesting and understanding. How can I help you? Absolutely. Well I bought Meta just ahead of earnings, which turned out to be a mistake. And I've made a lot of money off that stock over the years, but I I was trying to get back in it and uh
10:52
Unidentified speaker (UNKNOWN): that didn't play out well. But I want to know if it's a good if now is a good time to to jump back in into that.
10:58
Unidentified speaker (speaker_0): I I like Meta here. I
11:03
Unidentified speaker (speaker_0): be out. Uh probably maybe out is what I'm talking. And and that could because it's such a big stock and you get a chance to buy it cheaper, I would go do it. Let's go to Gus in Georgia, please, Gus.
11:14
Unidentified speaker (UNKNOWN): We are Jim. This is Gus in Atlanta. Hey
11:18
Unidentified speaker (speaker_0): Gus.
11:18
Unidentified speaker (UNKNOWN): Jim, I'm a I'm
11:19
Unidentified speaker (speaker_1): a proud investing club member, and I've
11:22
Unidentified speaker (UNKNOWN): had the honor
11:23
Unidentified speaker (speaker_1): of meeting you and Jensen Wong last fall at your investment club meeting at the New York Stock Exchange. What an incredible experience that was.
11:31
Unidentified speaker (speaker_0): Thank you. Thank you.
11:33
Unidentified speaker (speaker_1): And Jim, I start and end every day watching you on CNBC. I love your book, How to Make Money in Any Market.
11:40
Unidentified speaker (speaker_0): Thank
11:40
Unidentified speaker (UNKNOWN): you.
11:41
Unidentified speaker (speaker_1): Truly changed my life. My family and I, thank you.
11:44
Unidentified speaker (speaker_0): Thank you. I really appreciate that. Thank you very much.
11:47
Unidentified speaker (speaker_1): Oh, thank you. So my question is about Jersey mics with former Wing Stop CEO Charlie Morrison at the helm, aggressive US expansion and international growth beginning in London last week. I love its potential. Jim. the stock's been down, but it's starting to rebound. What's your take? Yeah,
12:06
Unidentified speaker (speaker_0): it's starting to, I think it's an inexpensive stock.
12:09
Unidentified speaker (speaker_0): Relative to what I think Charlie's going to be able to do. I was not happy, you know, right out of the shoot, the first numbers were not what I wanted, but I think they can get better because Charlie's that
12:18
Unidentified speaker (UNKNOWN): good. All right.
12:19
Unidentified speaker (speaker_0): Uh typically I just talk about what's going to be on Man Money tonight.
12:22
Unidentified speaker (UNKNOWN): Uh we're we're
12:23
Unidentified speaker (speaker_0): reading the tenses out,
12:24
Unidentified speaker (UNKNOWN): okay?
12:24
Unidentified speaker (speaker_0): Now
12:24
Unidentified speaker (UNKNOWN): I
12:24
Unidentified speaker (speaker_0): gotta tell you, I have to scramble,
12:26
Unidentified speaker (UNKNOWN): you
12:26
Unidentified speaker (speaker_0): have to scramble. I feel terrible that I didn't
12:28
Unidentified speaker (UNKNOWN): cut
12:28
Unidentified speaker (speaker_0): that
12:28
Unidentified speaker (UNKNOWN): I didn't
12:29
Unidentified speaker (speaker_0): cut this one big
12:30
Unidentified speaker (UNKNOWN): day.
12:30
Unidentified speaker (speaker_0): It happens.
12:31
Unidentified speaker (UNKNOWN): Actually,
12:32
Unidentified speaker (speaker_0): no, it doesn't
12:32
Unidentified speaker (UNKNOWN): happen. This is incredible. And uh
12:35
Unidentified speaker (speaker_0): sometimes incredible things happen,
12:37
Unidentified speaker (UNKNOWN): and it's
12:38
Unidentified speaker (speaker_0): just too bad.
12:39
Unidentified speaker (UNKNOWN): We
12:39
Unidentified speaker (speaker_0): are gonna talk about the upcoming anthropic IPO. We're focusing on one of the more convoluted aspects, profitability. And don't miss my analysis. Then are the restaurant stocks poised for a comeback amid a tough tape for tech? Let me go off the charts to find out. Hebva Far's Farmer Sudel's got some really good stuff. We're gonna sit down with the CEO. And again, look, am I broken
12:57
Unidentified speaker (UNKNOWN): up?
12:59
Unidentified speaker (speaker_0): Nothing's in my life that's broken up, but not this one. This one's just disgusting. Stablecreme.
13:13
Unidentified speaker (UNKNOWN): Don't
13:13
Unidentified speaker (speaker_1): miss a second of mad money. Follow at Jim Kramer on X. Have a question? Tweet Kramer. Hashtag MadMentions. Send Jim an email to madmoney at cnbc.com. Or give us a call at 1-800-743-CNBC. Miss something? Head to madmoney.cnbc.com.
13:36
Unidentified speaker (speaker_1): How does Edward Jones do money? differently?
13:40
Unidentified speaker (speaker_2): Our financial advisor would listen to us and actually really get to the meat and potatoes of what our lifestyle is and what we believe in.
13:49
Unidentified speaker (speaker_3): Knowing our financial advisor was always there. We could call him with anything at any time.
13:56
Unidentified speaker (speaker_1): We do money differently by providing advice that actually fits you.
14:07
Unidentified speaker (speaker_0): AI is here, transforming how we work, live, and lead. And the women I talk to aren't waiting for the future, they're shaping it. I'm Julia Borston, Senior Media and Tech Correspondent at CNBC. This is CNBC Changemakers, Makers, where I talk with the female leaders transforming business as AI reshapes the world.
14:27
Unidentified speaker (speaker_0): Follow and listen to CNBC Changemakers, women leading
14:30
Unidentified speaker (UNKNOWN): in the age of AI, wherever you get your podcasts.
14:43
Unidentified speaker (UNKNOWN): This
14:44
Unidentified speaker (speaker_0): week we're running a know your IPO series on anthropic, ahead of the company's IPO next week. I want you to be fully prepared. for what looks like the largest IPO in history. So I'm covering the story from all angles. Last night I talked about the incredible growth that Anthropic has shown, which is the main reason why its valuation is soared and there's so much interest in this deal.
15:04
Unidentified speaker (speaker_0): But tonight I'm going to tackle a more difficult subject. Tonight I'm going to tackle
15:08
Unidentified speaker (UNKNOWN): the
15:09
Unidentified speaker (speaker_0): company's profitability. I want to start with the most positive points, most notably on an adjusted operating income basis, Anthropic became profitable for the first time in the second quarter of 2026. And its adjusted operating margin, adjusted operating income divided by revenue, was positive again in the third quarter, even as it fell a bit from the
15:28
Unidentified speaker (speaker_0): second quarter. Looking at the first nine months of 2026 as a whole, Anthropic is profitable
15:35
Unidentified speaker (speaker_0): on both an adjusted operating income and adjusted network. net income basis. To be clear, Anthropic is achieving profitability, even on this adjusted operating income basis, is no small matter. Last night, the Wall Street Journal reported some third-quarter results for Anthropic's chief rival, OpenAI, and the key takeaways were that OpenAI's revenue growth accelerated in the third quarter. Oh,
15:55
Unidentified speaker (speaker_0): that's positive. But it is still deeply unprofitable, with an adjusted operating margin of negative 109%. Truly, Anthropic is doing much better on the profitability front than OpenAI. And that's a big reason why it is going to be the first of the two leading AI labs to make it to market.
16:12
Unidentified speaker (UNKNOWN): Now,
16:12
Unidentified speaker (speaker_0): on a more stringent, generally accepted accounting principles, where you may see that as gap basis, Anthropic is not yet profitable. But it's close, at least for the operating income line. So now I want to dig into the adjustments that are being made here. which move anthropic's financial results from the red to the black, as
16:31
Unidentified speaker (speaker_0): adjusted often does. The good news is that for adjusted operating income metric, there's not actually that much scrubbing being done. Basically, anthropic is backing out stock-based compensation and non-cash charitable contributions. That's the only difference between its gap operating losses and its adjusted operating income. But wait a second, is it fair to back out? stock-based
16:51
Unidentified speaker (speaker_0): compensation? That's for you to decide, but I will say that most major software companies do it. In theory, I don't love backing out stock-based compensation. Why? Because compensation seems like a legitimate expense to me. It should be included. But I'm also a pragmatist. And if I decided to die on that hill, I would have missed out on many great growth stocks over the
17:11
Unidentified speaker (speaker_0): years.
17:12
Unidentified speaker (UNKNOWN): Now
17:12
Unidentified speaker (speaker_0): let's talk about the difference between anthropics net loss. and adjusted net income, which is much more substantial. Specifically, again, using that term gap, the gap numbers, Anthropic reported a net loss of just over $104 billion through the first nine months of 2026, but its adjusted net income showed a profit of $5.6 billion.
17:32
Unidentified speaker (speaker_0): Now, how is that That's possible?
17:34
Unidentified speaker (UNKNOWN): Well,
17:34
Unidentified speaker (speaker_0): the key swing factor was a $94 billion line item and expense described. as the change in fair value of convertible notes, derivative liabilities, and safes. That's all cap safes, with safes standing for simple agreements for future equity. Without getting too bogged down, I know it's hard not to.
17:54
Unidentified speaker (speaker_0): Here's what's what this is about. Over the past couple years, Anthropic has reached wide-ranging agreements with some partners. Yeah, part big Big name partners, uh, Google, Amazon. and that include uh many different things. For example, Anthropic gets compute resources from these companies and distribution for its models via their cloud platforms. But in exchange, it also has committed to spend billions of dollars with those
18:13
Unidentified speaker (speaker_0): companies. And to this point, Anthropic also issued convertible notes, essentially debt securities that can be converted into anthropic equity, as well as other types of securities, to Amazon, Google, and other part partners. But as the value of Anthropic has increased substantially, the value of those securities it issued to its partners well is it they've grown as well. Each
18:33
Unidentified speaker (speaker_0): time there's a milestone where Anthropic gets a new higher valuation, it has to account for the increase in the value of those securities at at a cost.
18:43
Unidentified speaker (speaker_0): Crucially, it's a non-cash cost for Anthropic that matters. But while many investors seem happy to dismiss those huge charges because they're non-cash. not cash, I'm not sure they should be ignored entirely. And this brings me to my last most important point. There's one element to the anthropic IPO perspective that's a bit of a mystery, and that's the fact that the company has
19:02
Unidentified speaker (speaker_0): spent very little of the cash that it's raised. Specifically since its inception, Anthropic has raised approximately $141 billion of capital.
19:14
Unidentified speaker (speaker_0): But as of the end of September, it had a total of $132 billion in cash, cash equipment, and short-term investments on its balance sheet. Okay, how is that possible? Especially since the company's not cash flow positive. It reported its first positive cash flow from operations this year, but even then, it spent much more on investments than it generated from its operating incomes, right? Operating own operations. This is
19:34
Unidentified speaker (speaker_0): a head scratch. But the answer lies again in those huge deals with the likes. of Google and Amazon. Basically, rather than paying cash for its compute, it's given stakes in the company to its partners. So while you might dismiss those large non-cash charges as the value of those stacks, set of stakes have grown, I might argue that they are
19:54
Unidentified speaker (speaker_0): a good approximation of what the company would be paying were it to have paid cash for its infrastructure. But here's the more important point. Anthropic has also disclosed in its IPO prospectus that it has made enormous infrastructure spending commitments for the next several years. I've talked about some of these
20:14
Unidentified speaker (speaker_0): previously. Remember how I said they'll be paying over $3 billion per month per month to rent SpaceX Compute starting next month? That's part of a $120.5 billion deal with SpaceX. that runs through 2029. And that's just one of many such infrastructure agreements that Anthropic has made. It has others with Google and Amazon, as well
20:33
Unidentified speaker (speaker_0): as Microsoft, and a couple of neo clouds, Nscale, Lambda. Anthropic also has reached agreements directly with broad with chipmakers like Broadcom, AMD for even more compute. All told, Anthropic says in its IPO perspectus prospectus, that it is committed to spend approximately $900 billion, substantially all of which is related. to compute and infrastructure. About half of that
20:53
Unidentified speaker (speaker_0): will happen by the end of 2030, and about 70 billion is expected to be spent in the next year. Long story short, Anthropoc's compute costs, its cash compute costs, they are going to explode.
21:07
Unidentified speaker (UNKNOWN): Now,
21:07
Unidentified speaker (speaker_0): Anthrobic published its IPO Roadshow Road show's presentation yesterday. And in that deck, they offer what they call a quote, long. long-term financial framework, end quote, which shows how they think this will all work out. Basically, they expect to spend 45 to 50% of their revenue on compute and infrastructure, plus another 7 to 10% on revenue apiece on sales
21:27
Unidentified speaker (speaker_0): and marketing, and all other costs, including personnel. It all works out, they say, to a roughly 35% adjusted operating margin in the long run. Well, that's all well and good, but with the numbers for computer. compute commitments and the fact that Anthropic expects that spending to amount to less than half of revenue in any given year, you gotta assume that this company is going
21:47
Unidentified speaker (speaker_0): to continue, continue growing substantially to the point where it has hundreds of billions of dollars in revenue per year. And soon, that's the only way this works. But it might work.
21:57
Unidentified speaker (UNKNOWN): And
21:58
Unidentified speaker (speaker_0): that really is the bottom line here. When it comes to Anthropic's profitability, yes, the company has achieved. profitability, but only if you strip out some key costs that some would say, including me, shouldn't be stripped out. But the more salient point is that Anthropic is due to spend an enormous amount in the future. So it needs to continue growing rapidly to outrun those costs and remain profitable.
22:17
Unidentified speaker (speaker_0): That's the bet you're making. If you buy the Anthropic IPO. And just to tell you, look, after all this, I pull call me. intrigued because it is one fast growing company and I care about growth. Their money is back after the ring.
22:34
Unidentified speaker (speaker_1): Coming up, Kramer's going off the charts to see which restaurant stocks are best positioned
22:40
Unidentified speaker (UNKNOWN): to succeed in the current rotation. Next.
22:45
Unidentified speaker (speaker_1): How does Edward Jones do money differently?
22:49
Unidentified speaker (speaker_2): Our financial advisor would listen to us and actually really get to the meat and potatoes of what our lifestyle is and what we believe in.
22:58
Unidentified speaker (speaker_3): Knowing our financial advisor was always there. We could call him with anything at any time.
23:05
Unidentified speaker (speaker_1): We do money differently by providing advice that actually fits you.
23:16
Unidentified speaker (speaker_2): AI is here, transforming how we work, live, and lead. And the women I talk to aren't waiting for the future, they're shaping it. I'm Julia Borston, Senior Media and Tech Correspondent at CNBC. This is CNBC Changemakers, where I talk with the female leaders transforming business as
23:34
Unidentified speaker (speaker_1): AI reshapes the world. Follow and listen to CNBC Changemakers.com. Changemakers, women leading in the age of AI, wherever you get your podcasts.
23:53
Unidentified speaker (speaker_0): For the past several weeks, as investors have rotated out of tech stocks and the AI trade, many have moved into other groups that have previously been struggling, including many. consumer discretionary sectors like the restaurant stocks. When gas prices and interest rates spiked in the back half of the summer, investors left most of the consumer discretionary stocks, as they're called, for dead,
24:13
Unidentified speaker (speaker_0): fearing that squeezed consumer budgets would result in weak spending and make for a tougher operating environment for retailers and restaurants, as it always has. But that has something turned out to be wrong. We had sequentially positive retail and food services sales growth in both August and September. And it was the food services category doing a lot of the heavy lifting those months. Really kind of extraordinary. Once investors started
24:33
Unidentified speaker (speaker_0): fleeing tech last month, many restaurant stocks started to rally hard. In just the past few weeks, we've covered several of them, including Chipotle, which you know we called the bottom one. Uh Brinker Eat, we
24:43
Unidentified speaker (UNKNOWN): like
24:43
Unidentified speaker (speaker_0): that, McDonald's, we say it's good, Texas Royales, and Starbucks. Now the latter has turned into a big win for my travel trust, which of course you can follow by joining the CMU. CBC Investing Club. To help find some more restaurant stocks that are working in this group, we reached out to Bob Lang, old friend, founder of Explosive Options.net and the author of Know Your Options, who said he sees
25:03
Unidentified speaker (speaker_0): more upside in three fast food stocks. He likes Wingstop, he likes Shake Shack, and he likes Restaurant Brands International. All three of these copies have delivered strong earnings results in recent weeks. Lang says that they've been able to. take price without hurting demand. Highly unusual in this environment. And with relatively low comps from earlier this year, he thinks this could
25:22
Unidentified speaker (speaker_0): be a sleeper group that's primed to do well into next year as well. But most of all, he likes what he sees from these charts. Okay, we're going to start with one that I haven't been a big fan of at all since it blew up a long time ago. It's called Wing Stop, which uh this one he calls his favorite name in the group. Wang Wing shares have been under pressure for most of the year, but they've had a massive rally, climbing
25:42
Unidentified speaker (speaker_0): 74% from their late September lows. This is a really nice move. Okay. The rallies come with good volume trends recently, Lang says, and the stock broke out above the some important medium-term resistance levels in mid-October. Here at the bottom, which we're looking at, it's is the MACD moving average convergence divergence line. Uh this indicator, which
26:02
Unidentified speaker (speaker_0): trade significantly technicians use to measure momentum strength, is now firmly on a buy signal. You can see that really well. At the top, the RSI, a relative strength index. The wing stop shows a stock is in overbought territory. But Lang says there's no reason to be a seller. Sometimes it's just an incredible show of strength. Okay.
26:23
Unidentified speaker (UNKNOWN): Um
26:23
Unidentified speaker (speaker_0): Now, he likes that the stock recently retested the 200-day 200 moving. day average in red and held. That level has gone from resistance to support. Overall, he thinks the recent pattern of higher highs and higher lows for wing shares is a textbook bullish setup. He could see this hundred and sixty seven dollar stock make a run first to two hundred and eventually to two hundred and fifty dollars. This would
26:43
Unidentified speaker (speaker_0): shock me, and I don't care for the stock, but I am a huge fan of Bob Lang's work. Next, let's take a look at the chart of Shake Shack, uh, which gap gapped down after a bad earnings miss in May and has spent most of the past six months in the penalty box. But Lang thinks that the huge gap lower on high volume got some weak hands out of the stock.
27:03
Unidentified speaker (UNKNOWN): Look
27:03
Unidentified speaker (speaker_0): at that, huh? And then you got this real long base that Shaq has had, just what the Bulls need. At this point, many investors are skeptical about buying the stock, but Lang says that makes it a perfect time to. be getting long. He noted the stocks break out above the 200-day moving average. Now the 200 day is in red here. You've got a right, you're we're starting to really
27:23
Unidentified speaker (speaker_0): see some. This is a fabulous sign. Uh a powerful move. Here at the bottom, Lang points out that the MACD recently made a bullish crossover as well. Though he does note that the RSI up here at the top of the chart shows the stock is approaching overbought territory. But he also says that the options flow look good for Shake Shack with a lot of interest in the call options at the $75 and
27:43
Unidentified speaker (speaker_0): $80 strike expiring later this year and into the first half of 2027. Bob always looks at that stuff. I always thought I respected his work like that. Overall, Lang thinks the gap from May will be filled within the next few weeks. And if he's right, that means about 20 points or maybe 25% upside for Shake Shack, a stock that is expensive.
28:03
Unidentified speaker (speaker_0): and again, I've been cautious on. I'm growing less cautious when I listen to Bob. The last stock that Lang likes is restaurant brands, QSR, Parent Company of Burger King, Popeyes, Tim Hortons, and the smaller firehouse subs. This stock has been range-bound for months with a fairly wide range on modern volume. Lang says that means the big money is
28:23
Unidentified speaker (speaker_0): trying to figure out this one. Each time it moves into the 80s, and you can see this, this very interesting pattern, uh, it it gets knocked back down. Bulls and bears alike are getting frustrated with this stock. Sure, they are bounced, bounce, but you know, knocked down, knocked down. Could it happen again? But QSR's strong start to this month has caught Lang's attention. The MACD here at the bottom has
28:42
Unidentified speaker (speaker_0): flipped to a strong buy signal. This is that flip right here, okay? Uh and the the average, this chart, it's all starting to turn as well. Uh the R. RSI at the top of the chart shows there's still some room before this one gets too overbought. He likes that. Lang points out that the volume trends here are becoming more bullish as well. You see the volume getting a little bit higher. Overall,
29:02
Unidentified speaker (speaker_0): Lang wants to watch QSR shares closely as they reapproach the low 80s, a level that has represented resistance a couple times already this year. But if restaurant bears brands can break out above the key 81 to 82 dollar level, that would be extremely bullish. Lang says a move. through that level would confirm a breakout, and the stock could easily make it to the triple digits. Here's the bottom line: the
29:22
Unidentified speaker (speaker_0): charges interpreted by Bob Lang show that the restaurant stocks have made an excellent move higher in recent weeks. But Lang thinks there's still more upside for some of them. He likes Wing Stop Best, thinks Things Shake Shack Shaq is looking good, and restaurant brands, well, he's approaching, he says it's approaching. major tests as they move back toward press uh previous highs. Now,
29:42
Unidentified speaker (speaker_0): if the stock passes that test, then he thinks there's an awful lot of room to run. Chris in Louisiana. Chris.
29:49
Unidentified speaker (UNKNOWN): Hey
29:50
Unidentified speaker (speaker_2): Jim.
29:51
Unidentified speaker (UNKNOWN): All
29:51
Unidentified speaker (speaker_0): right, what's happening?
29:52
Unidentified speaker (UNKNOWN): Jim. Can
29:53
Unidentified speaker (speaker_2): we
29:53
Unidentified speaker (UNKNOWN): talk steaks? Yeah,
29:55
Unidentified speaker (speaker_0): why not?
29:56
Unidentified speaker (speaker_1): Darden restaurants. Darden restaurants, Jim. Should I saddle up or should I saddle out?
30:02
Unidentified speaker (UNKNOWN): I think.
30:02
Unidentified speaker (speaker_0): that look, I think Darden is absolutely terrific. They offer great value at Olive Garden. I think you should continue to buy the stock. It's even though it's on the spike, I think it does go higher. All right, there's much more med money ahead, including my exclusive with Teva Pharmaceutical. Then this Veterans Day, I'm shining a light on one fantastic executive whose military service influenced his career and the company itself. And of course, all your calls rapid
30:22
Unidentified speaker (speaker_0): fired tonight's edition of the lighting round. So stay with Kramer.
30:34
Unidentified speaker (speaker_0): Recently, Teva Pharmaceutical, one of the world's largest drug makers, released some solid earnings to beat on both the top and bottom lines and a raise of its full year sales forecast. Under Richard Francis, who took over in early 2023, Teva's put more money behind its own branded drugs and its in transformation. from a pure plate generics company to a biopharma. This
30:54
Unidentified speaker (speaker_0): was a $9 stock when Francis took the job. It's now above $43. Today, at its first ever RD day, Teva laid out how its innovative medicines could bring in six to seven billion dollars a year by 2030. Can the next wave of drugs keep this stock running? Let's check in with Richard Francis, Teva's Teba's present CEO. Mr. Bishop Francis,
31:14
Unidentified speaker (speaker_0): welcome back to Bad Man Money.
31:15
Unidentified speaker (UNKNOWN): Thanks,
31:15
Unidentified speaker (speaker_1): Jim. Pleasure to be here.
31:16
Unidentified speaker (speaker_0): I tell you, Rich, I I had to stop myself. I was thinking about this because there would there would have been no reason to have an RD day before
31:24
Unidentified speaker (UNKNOWN): you
31:25
Unidentified speaker (speaker_1): Yeah, no, it's true. Actually, I when I presented today, my first thing I said on the stage was,
31:30
Unidentified speaker (UNKNOWN): this
31:30
Unidentified speaker (speaker_1): is Teba's first ever RD day.
31:33
Unidentified speaker (speaker_0): I remember speaking with previous Tebas TEVA CEOs, and they wanted to come on the show, and I would always say no, because it would always be I felt an embarrassing thing. What have you stolen here? What have you got what copyright have you broken there? You are breaking ground in some things that when I saw you in January, I actually was quite critical of because I didn't think you could do
31:51
Unidentified speaker (UNKNOWN): it.
31:51
Unidentified speaker (speaker_0): And you have succeeded. Uh on migraine, on uh tartive dyskinesia, you're doing some incredible things in schizophrenia. I don't even know where to begin. These are all things I feel that companies won't target, as I mentioned in January. They don't go after it because what happens is at their analyst day, they have to say, I'm sorry, we struck out. What are you doing right
32:11
Unidentified speaker (speaker_0): that the other guys can't do?
32:13
Unidentified speaker (speaker_1): Well, I think what we actually uh outlined today in our RD strategy is we're sort of pragmatic. We go after things where we think there's a high probability of success. We really understand the science deeply, and then we think, okay, we can we can make something uh successful. And a good example of this is well true is a long actinalzepine that we launched just a few weeks ago. Now a
32:33
Unidentified speaker (speaker_1): lanzepine as a molecule is regarded as the most efficacious treatment for schizophrenia. The challenge has been no one's been able to make a long actin injectable. Now obviously compliance and adherence for schizophrenia patients who suffer from severe schizophrenia is really important.
32:47
Unidentified speaker (speaker_0): You don't have to be you don't have to do it at the doctor's office, you don't have to monitor it.
32:51
Unidentified speaker (speaker_1): No, there's no monitoring required
32:52
Unidentified speaker (UNKNOWN): for
32:53
Unidentified speaker (speaker_1): our well choosers. So what we thought, okay, how do we crack this long acting? And so we spent a lot of time working on that. But so one could say that we knew the molecule worked, we just had to make it long acting and once monthly. And when we did that and we launched it, the reception we received from the psychiatric community and the patients It's has been really, really positive because that's the unmet medical need. So I think what we do really
33:13
Unidentified speaker (speaker_1): well is we go after real patients unmet medical need, focus where we have real capability, whether it's drug delivery or whether that's innovative mechanisms, and then we really prosecute it aggressively and we move fast.
33:25
Unidentified speaker (speaker_0): Well, I I would point out that I have been with another drug company that recently failed on schizophrenia, and they told me that the reason why is because it's just too hard. There's really no hope. So obviously they should attend to your meeting. Maybe they would have found that out.
33:39
Unidentified speaker (speaker_1): It's hard. It is hard.
33:40
Unidentified speaker (speaker_0): Okay, so let's talk about uh bipolar, because bipolar is another one that a lot of drug companies have kind of said, well, let's just leave it to lamictol. Let's leave it to a 1950s anti-seizure drug. Why are you not content with the 1950s anti-seizure drug as a way to be able to treat bipolar?
33:56
Unidentified speaker (speaker_1): Well, I think what we noticed when we launched uh EUCEDI are our long acting active for perospiridone, spirit. So we now have Eusetti, EUCEDI, which is long acting, actin,
34:01
Unidentified speaker (UNKNOWN): and a
34:02
Unidentified speaker (speaker_1): lambs lanzepine have been a long the act. long actin. So we really
34:03
Unidentified speaker (UNKNOWN): have, I think,
34:04
Unidentified speaker (speaker_1): an ability to help about 85% of patients who suffer from schizophrenia
34:08
Unidentified speaker (UNKNOWN): with
34:08
Unidentified speaker (speaker_1): well-known molecules.
34:09
Unidentified speaker (UNKNOWN): When it came
34:10
Unidentified speaker (speaker_1): to EUCEDI, we expanded that indication into bipolar about 12 to 18 months ago.
34:15
Unidentified speaker (UNKNOWN): And
34:15
Unidentified speaker (speaker_1): obviously, you know, that's the potential we can do with the same with a lanzepine. But what is interesting, Jim, is we've
34:20
Unidentified speaker (UNKNOWN): just uh bought
34:21
Unidentified speaker (speaker_1): uh
34:21
Unidentified speaker (UNKNOWN): uh
34:22
Unidentified speaker (speaker_1): an acid from
34:23
Unidentified speaker (UNKNOWN): a company, uh
34:24
Unidentified speaker (speaker_1): BioXL, bioxcel which will treat agitation for schizophrenia.
34:27
Unidentified speaker (speaker_3): and bipolar at home. So that's another area where patients really don't have treatment because obviously agitation with bipolar and schizophrenia is very common. Roughly about two to three million people have that symptom but they can't be treated at home so they have to go into hospital, into a clinic. So that's just another area where we're treating both schizophrenia and bipolar, but building out on our our
34:47
Unidentified speaker (speaker_3): our our schizophrenia franchise to a real schizophrenia scale. And
34:51
Unidentified speaker (speaker_0): Adjovi, how is that different from Nuretech or Amivic?
34:55
Unidentified speaker (speaker_3): So uh so Adjovi is a great story. So when we start on the pivot to growth, no one was talking about Adovy. People thought it had its day. It was $400 million. This year we're going to do over $900 million, and we've got peak cells of over a billion dollars. The reason why it's doing so well is because
35:09
Unidentified speaker (speaker_0): for migraine, I'm sorry.
35:10
Unidentified speaker (UNKNOWN): This
35:10
Unidentified speaker (speaker_3): is for migraine, a long-acting long acting treatment for migraine, it's a long uh an injectable ejectable CGRP. And the reason why it's done really well is per firstly, it's it's a great product profile, it's very efficacious, it's convenient for the patient. But I think this goes back to our commercial capability at Severa as well. We really understand the patient journey, whether it's in the United States, whether it's in Europe, or other markets. We have grown our market share
35:30
Unidentified speaker (speaker_3): contextually.
35:31
Unidentified speaker (speaker_0): Even though it is, it is, is it a copycat CGR product? provider?
35:34
Unidentified speaker (UNKNOWN): No,
35:34
Unidentified speaker (speaker_3): no. This is an innovative product we brought to the market many years ago. But I think in our hands, what we've shown under the pivot to growth, we invested more, we understood more, and we did the pediatric indication. Often forgotten. You launch a drug and then you don't do the pediatric.
35:48
Unidentified speaker (UNKNOWN): Very
35:48
Unidentified speaker (speaker_0): good point. There is no pediatric for the ones I'm talking about. Finally, 2027, what do you have?
35:53
Unidentified speaker (speaker_3): 2027. It's going to be a pretty busy year. So obviously we launched World Truths at the end of this year. Um we'll have that for the first school next year. We'll launch EcopiPan, Ekopipan, uh a treatment for uh Tourette syndrome. So that's a deal
36:04
Unidentified speaker (UNKNOWN): we did last year. No,
36:05
Unidentified speaker (speaker_0): another one that people say you can't be cured.
36:07
Unidentified speaker (speaker_3): Exactly. So I'm super excited about as a father of three, just the idea that we can help children in their formative years in a very difficult condition. And then obviously we hope to be launching uh uh the the treatment that we got from uh the acid that we bought out of ISXL. And and then just keep driving a Jovi, UCEDI, Waltruza, Waltrusa, and a Esteto, steto, I a think treatment we've for targeted talked of dyskinesia, which was up. thirty
36:27
Unidentified speaker (speaker_3): percent in quarter three. So we have those, and then we have one launch every five years for the next five years, and then we have a launch probably every eighteen months.
36:35
Unidentified speaker (UNKNOWN): Well, you should be
36:35
Unidentified speaker (speaker_0): very proud of what you're doing. I do a lot of work with the with the brain because of problems with the brain. I don't mind saying that. Um people are not supposed to talk about it. That's a that's why brain doesn't get solved, because no one talks about it. I do, from the American Brain Foundation. The stuff you're tack tacking tackling is incredible.
36:51
Unidentified speaker (UNKNOWN): And I
36:51
Unidentified speaker (speaker_0): I I thank you.
36:52
Unidentified speaker (UNKNOWN): Well, I
36:53
Unidentified speaker (speaker_3): thank you for talking about it, Jim.
36:54
Unidentified speaker (UNKNOWN): Absolutely. Thank you for
36:55
Unidentified speaker (speaker_3): having us on the show.
36:56
Unidentified speaker (speaker_0): Of course. It's Richard Francis, CEO of Teva Pharmaceutical. The old Teva wouldn't I wouldn't put on. This Teva, I take mid Money Spec here for the break.
37:06
Unidentified speaker (speaker_3): Coming up, he's the fastest mind on Wall Street. So we're putting him to the test with your help. Bring on the lightning round. Next.
37:23
Unidentified speaker (speaker_0): It is time. It's up for the white rail crits.
37:27
Unidentified speaker (speaker_0): Bye-bye. So we're doing the course talk quite my standards if we have someone playing the sound.
37:32
Unidentified speaker (UNKNOWN): And
37:32
Unidentified speaker (speaker_0): then the lightning round is over. Are you ready, Steve? Daddy time Tom for the White Lightning Rail Round Crimson. Cream. We're about to start with Ronald and Florida Ronald.
37:41
Unidentified speaker (speaker_1): Jim Ronald from Wellington, Florida. Alibaba.
37:46
Unidentified speaker (UNKNOWN): I
37:46
Unidentified speaker (speaker_0): think Alibaba is the only Chinese stock that I would possibly buy. It's not my favorite right now because the consumer is so weak in China, but it is the only one that I would buy. Let's go because it's got American Financiers. Let's go to Roy in New Jersey. Roy.
37:58
Unidentified speaker (UNKNOWN): Well, really
37:59
Unidentified speaker (speaker_0): happy. Hey,
38:00
Unidentified speaker (speaker_1): Jim Boy, it's a great pleasure for me to be talking. to you.
38:03
Unidentified speaker (speaker_0): Uh, you're very kind, boy.
38:05
Unidentified speaker (UNKNOWN): What's going
38:05
Unidentified speaker (speaker_0): on?
38:06
Unidentified speaker (UNKNOWN): The
38:06
Unidentified speaker (speaker_1): ticket I have is TGB, Cyclore Metals.
38:11
Unidentified speaker (speaker_0): Speculative copper stock, speculative copper stock, a lot of copper stock, still the copper still being used in the data center because they haven't converted it to fiber yet. I think you can catch a good one. Let's go. But it's back. Robert in Florida. Robert.
38:23
Unidentified speaker (UNKNOWN): Hello,
38:24
Unidentified speaker (speaker_1): Jim.
38:25
Unidentified speaker (UNKNOWN): Robert.
38:25
Unidentified speaker (speaker_0): Robert and
38:25
Unidentified speaker (speaker_1): in beautiful beautiful sample Tampa, copper. Florida. Thanks for taking my questions.
38:29
Unidentified speaker (speaker_3): My pleasure.
38:30
Unidentified speaker (UNKNOWN): I'm
38:31
Unidentified speaker (speaker_1): long uh DraftKings at about 25, and as you know, they got hammered after the quarter three earnings. Um I'm concerned about their customer acquisition costs and and competition from companies like But Calci. Calce. Um I learned though that that's I'm
38:48
Unidentified speaker (UNKNOWN): not sure. I think you're right. I think you're right
38:49
Unidentified speaker (speaker_0): to be concerned. There's way too much competition. I don't know. It's it's withering competition. Everybody's a loser, and I don't and I think there's too much gambling in the country. That's my own personal view. But it's also been the view becoming to be the prevailing view at the investment houses of this country. I no longer can possibly recommend any of these gambling stocks because they're all one big gamble. Let's go to
39:09
Unidentified speaker (speaker_0): Bill in Texas. Bill.
39:12
Unidentified speaker (UNKNOWN): Who
39:12
Unidentified speaker (speaker_1): Whoya, ya, Jim?
39:13
Unidentified speaker (speaker_0): Whoa. Whooya.
39:14
Unidentified speaker (speaker_1): Proud proud club member here and uh
39:17
Unidentified speaker (UNKNOWN): long time
39:18
Unidentified speaker (speaker_1): listener.
39:19
Unidentified speaker (UNKNOWN): Uh
39:19
Unidentified speaker (speaker_1): you're still the best.
39:21
Unidentified speaker (speaker_0): Oh, thank you, man. Thank you. Thank you very much. Thank you. How can I help?
39:25
Unidentified speaker (speaker_1): I want to get your thoughts on one of my favorites. Uh Origin Bank Card, symbol OBK.
39:32
Unidentified speaker (speaker_0): You know, I've got to tell you, I've actually made a lot of money by Louisiana Banks over the multiple years because there's a lot of consolidation then. in them. This is an inexpensive bank stock, not that good a yield, but I like it. I think you got a good one. Then I and I actually would encourage you to buy it. Let's go to John in New Jersey. John.
39:48
Unidentified speaker (UNKNOWN): Oh
39:49
Unidentified speaker (speaker_1): yeah, Jim.
39:50
Unidentified speaker (speaker_0): Oh yeah.
39:51
Unidentified speaker (speaker_1): Um
39:52
Unidentified speaker (speaker_1): it's John from Ag Harbor Township. What's your opinion on Pound Pier?
39:57
Unidentified speaker (UNKNOWN): My dad did a lot of
39:58
Unidentified speaker (speaker_0): business in Ag Egg Harbor. There were like three retail stores and he sold bags too. Um I think that Pound Tier stock is worth $200 and Fries it isn't there yet. They did have an excellent quarter. Alex Carpus doing a terrific job. Let's go to Hank in Indiana. Hank.
40:12
Unidentified speaker (UNKNOWN): Yes. Hello, Mr. Kramer. Hey
40:14
Unidentified speaker (speaker_0): Hank, what's up?
40:16
Unidentified speaker (UNKNOWN): Thanks for taking my call. I'll get right to the point. All right.
40:19
Unidentified speaker (speaker_0): I'm in
40:19
Unidentified speaker (UNKNOWN): my mid-70s.
40:20
Unidentified speaker (speaker_1): My grandson's 10 years old. We both own shares in energy transfer.
40:25
Unidentified speaker (UNKNOWN): I
40:25
Unidentified speaker (speaker_1): bought the shares for potatoes. potential growth and its dividends. I got two questions. For my shares, should I buy more, hold or sell? For my grandson, should I buy more, hold or sell, and reinvest?
40:37
Unidentified speaker (speaker_0): Okay, for you I want you to buy more. I think it's certain. For your grandson, it's not risky enough. Believe it or not, what you have to do is you have to buy something that has more uh growth to it. And and but nothing crazy. I mean, I'm talking about a J and J. I'm talking about a Procter Gamble. I would do that because you do not need to worry. You got your whole he's got his whole life ahead up. I
40:57
Unidentified speaker (speaker_0): say don't do that. Buy something more aggressive. Let's go to SPARS in California. SPARS.
41:04
Unidentified speaker (speaker_0): Red, white, and blue, 250 years of American exceptionalism, Veterans Day. Booyah. Ski day. Booyah is right. And thank you. Thank you everyone for serving.
41:17
Unidentified speaker (UNKNOWN): All right.
41:20
Unidentified speaker (speaker_0): Dr. J, we're looking at NetScope, NTSK. You know, it's just one more cloud security platform. You know, we like CrowdStrike and we like Palo Alto Networks, and we don't need any more beyond that. And that, ladies and gentlemen, is the conclusion of the Lightning Round.
41:39
Unidentified speaker (UNKNOWN): The
41:39
Unidentified speaker (speaker_3): Lightning Round is sponsored by
41:41
Unidentified speaker (UNKNOWN): Charles
41:42
Unidentified speaker (speaker_0): Schwab.
41:43
Unidentified speaker (speaker_3): Coming up on this Veterans Day, Kramer is paying tribute to all those who served. Next.
41:58
Unidentified speaker (speaker_3): Tomorrow, kick off the trading day with Squawk on the Street.
42:04
Unidentified speaker (speaker_3): Live from Post 9 at the NYSE.
42:07
Unidentified speaker (UNKNOWN): I am sorry. I
42:08
Unidentified speaker (speaker_0): wish I had made
42:08
Unidentified speaker (UNKNOWN): it up. You know,
42:09
Unidentified speaker (speaker_0): it would have been better if I had said, David, I have an idea instead of what the truth is. But I'm stuck with the damn truth. Which you, by the way, cannot
42:19
Unidentified speaker (speaker_0): handle it.
42:20
Unidentified speaker (speaker_3): It all starts at 9 a.m. Eastern.
42:23
Unidentified speaker (speaker_1): Jim Kramer, the dipolog of the Dollar. Hey Jimmy, love the show. My five-year-old grandson loves to watch your show. I have to thank you for making us money when it's there to be made. Our world is a better place with you in
42:37
Unidentified speaker (UNKNOWN): it.
42:55
Unidentified speaker (UNKNOWN): We
42:55
Unidentified speaker (speaker_0): cannot go a whole show without saluting the men and women who serve and have served in our military on this November 11th, known since President Eisenhower as Veterans Day.
43:06
Unidentified speaker (UNKNOWN): It's
43:06
Unidentified speaker (speaker_0): a day where I find myself grasping at the greatness of those who serve who willing to put themselves in harm's way. Like the great Marine Colonel I write about at the beginning of how to make money in any market, a quiet hero who inspired me to start investing after he showed me how he started buying merc as soon as he got back from the war. He built a small fortune. My dad served too in the
43:26
Unidentified speaker (speaker_0): army. He won a battlefield commission, promoted in the midst of a battle when all above his rank were incapacitated or killed in the Battle of Lady Gulf in the Philippines. I didn't know what that meant. I didn't know what my hero of my father was until after he passed away. He was a simple soldier who signed up after Pearl Harbor and served in the Pacific. I didn't know he had done something heroic, though, until I went to an NFL
43:46
Unidentified speaker (speaker_0): football game with a man I revered for years and years, Fred Smith, who started FedEx and built it into the colossus that it is today before turning it over to Raj Superman in 2022. Fred died last year, and I wish his passing had gotten more attention, given the fabulous career he led and how much he did for veterans while he built FedEx. Fred went to Yale, where he studied
44:06
Unidentified speaker (speaker_0): economics and famously wrote a paper about starting an overnight delivery business, which he got either a C or a D on. Fred had forgotten the grade, but he remembered it was a bad one. After graduating, he's then signed up for the Marine Corps to serve in Vietnam. Several times Fred marveled Marvel to me uh about the old days when you just when you just did that because it was the right
44:26
Unidentified speaker (speaker_0): thing to do. do.
44:27
Unidentified speaker (UNKNOWN): He
44:28
Unidentified speaker (speaker_0): did two tours and retired as a captain. He received the Silver Star for gallantry in battle. His citation is too long to list, other than to say that he risked his life for his soldiers repeatedly in a battle against the North Vietnamese. In his first tour, he was a grunt, but in his second, he served as a forward air
44:48
Unidentified speaker (speaker_0): controller, guiding bombing strikes. When I saw him last, he took out a black and white picture of his platoon and told me how many of the men I was looking at were killed in the war. He pointed to each one. It was a somber moment, simply something Fred wanted me to see. He was determined to let me know of these soldiers, to remember them, and I do that
45:07
Unidentified speaker (speaker_0): this day. Fred I took some gambles literally when FedEx was in its infancy. At one point after being denied a loan, he took the company. company's last $5,000, flew to Las Vegas, and turned it into $27,000, playing Blackjack, saving the company in the process. He laughed about it when he told me the story. I asked him to tell it me a couple of times I liked it so much. His
45:27
Unidentified speaker (speaker_0): service in the military helped guide him through all the years and reversals of his fortune. His successor, Raj, told me today that FedEx culture was built on people first principles that Smith learned in the military. Our culture is our bedrock, Raj said. Lots of initial FedEx employees and pilots were from the military and still are from the military. Fred liked the
45:47
Unidentified speaker (speaker_0): American Battlefield Monuments Foundation, which maintains the beautiful cemeteries of Americans who died overseas. He had mentioned my dad in conjunction with that, because he said he told me my dad was a hero. Uh, And that's where I learned of it. I give to the foundation for my travel trust, and I do it in honor of. Fred. I know Fred will always be known as the person who started the amazingly
46:07
Unidentified speaker (speaker_0): successful FedEx, or the exec who opined most eloquently about the economy at the beginning of a bunch of T V shows I did. But when I spent time with him, he just wanted to talk about the importance of his time in the military and those who serves so their deaths and struggles were not in vain. Oh, he was quite the man, quite the veteran.
46:27
Unidentified speaker (speaker_0): Fred, on this day we salute you and the millions of others who have served, along with the men who serve with you in Vietnam, who never return. I like to say there's always a bull market somewhere, and I promise to try to find it just for you right here on May of Money. I'm Jim Kramer. See you tomorrow.
46:46
Unidentified speaker (UNKNOWN): All
46:46
Unidentified speaker (speaker_1): opinions expressed by Jim Kramer on this podcast are solely Kramer's opinions and do not reflect the opinions of C N B C or its parent company or affiliates, and may have been previously disseminated by Kramer on television, radio, internet, or another medium. You should not treat any opinion expressed by Kramer as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of his opinion.
47:09
Unidentified speaker (speaker_1): And our subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. To view the full Mad Money Disclaimer, please visit CNBC.com forward slash madmoney disclaimer. AI is here, transforming how we work, live, and lead. And the women I talk to aren't waiting for the future, they're shaping it. I'm Julia Borstin, Senior Media and Tech
47:29
Unidentified speaker (speaker_1): Correspondent at CNBC. This is CNBC Changemakers, where I talk with the female leaders transforming business as AI reshapes the world. Follow and listen to CNBC Changemakers, women leading in the age of AI, wherever you get your podcasts.
This page was produced automatically: the audio was transcribed with nvidia/parakeet-tdt-0.6b-v3+sortformer-v2.1 and interpreted by Qwen3.6-35B-A3B-UD-IQ3_S.gguf. Transcription and interpretation can contain errors; always confirm against the original episode. Nothing here is investment advice.

More from Mad Money w/ Jim Cramer

Mad Money w/ Jim Cramer

Mad Money: Wall Street Jargon, Cyclicals, GARP & Corrections 11/13/26

Episode discussion: Jim Cramer distinguishes cyclical from secular stocks and advises against holding REITs amid rate hikes

Speakers’ claims: Jim Cramer demystifies Wall Street jargon by contrasting cyclical stocks tied to economic cycles with secular growth companies that perform regardless of economic conditions. He recommends higher equity exposure for younger investors and suggests dollar-cost averaging into S&P 500 index funds for long-term goals. Cramer warns against holding REITs due to interest rate pressure and cautions investors against turning failed trades into long-term investments. He advocates for diversification, limiting any single sector to 20% of a portfolio, and emphasizes management execution over passive buy-and-hold strategies.

Cyclical vs Secular StocksREITsInterest Rates
49 min4 assets16 claims to verify
Mad Money w/ Jim Cramer

NVIDIA Without Jensen, Anthropic IPO Risks & Moderna’s Cancer Vaccine 11/12/26

Episode discussion: Cramer on NVIDIA CEO Exit, Anthropic IPO Risks, and Moderna's Cancer Vaccine Breakthrough

Speakers’ claims: Jim Cramer discusses the resignation of NVIDIA CEO Jensen Huang amid security and personal scandals, advising investors to take profits despite the company's strong fundamentals. He analyzes Anthropic's upcoming IPO, highlighting concerns about share unlock dynamics and pricing pressure compared to its massive cash balance. The episode also covers Kraft Heinz's strategic pivot away from a corporate split toward innovation and digital marketing. Finally, Cramer highlights Moderna's stock surge following positive melanoma vaccine data and details the company's personalized cancer treatment technology.

NVIDIAAnthropic IPOModerna
49 min3 assets17 claims to verify
All insights